Advanced design of the total disc replacement using modern engineering methods and progressive technologies
Public support
Provider
Technology Agency of the Czech Republic
Programme
Programme of applied research and experimental development ALFA
Call for proposals
ALFA 1 (STA02011TA01)
Main participants
ProSpon, spol. s r.o.
Contest type
VS - Public tender
Contract ID
20110057
Alternative language
Project name in Czech
Řešení problematiky náhrady meziobratlového disku s využitím moderních poznatků, inženýrských metod a progresivních technologií
Annotation in Czech
Hlavním cílem projektu je dosažení pokroku na světové úrovni v řešení problematiky náhrady meziobratlového disku, která je používána k léčení degenerativních onemocnění meziobratlového disku - závažného zdravotně-sociálního problému, nabývajícího na intenzitě u vyspělých společností v celosvětovém měřítku.
Scientific branches
R&D category
AP - Applied research
CEP classification - main branch
EI - Biotechnology and bionics
CEP - secondary branch
JI - Composite materials
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20505 - Composites (including laminates, reinforced plastics, cermets, combined natural and synthetic fibre fabrics; filled composites)<br>20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
This is preliminary data, no approval by the provider.
Solution timeline
Realization period - beginning
Jan 1, 2011
Realization period - end
Dec 31, 2014
Project status
U - Finished project
Latest support payment
Feb 28, 2013
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP15-TA0-TA-U/03:1
Data delivery date
Jul 3, 2020
Finance
Total approved costs
15,307 thou. CZK
Public financial support
11,867 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
3,440 thou. CZK